Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

34.47
Delayed Data
As of Mar 22
 +0.22 / +0.64%
Today’s Change
29.41
Today|||52-Week Range
37.39
+6.13%
Year-to-Date
4 Health Care Charts Signaling Buys: Pfizer, Amgen Included
Mar 21 / TheStreet.com - Paid Partner Content
CytomX Soars on Bristol-Myers Partnership
Mar 20 / TheStreet.com - Paid Partner Content
Nektar's Pain Drug Positive in Phase III Study; Shares Gain
Mar 21 / Zacks.com - Paid Partner Content
Companies Aiming for the Billion-Dollar Opioid Addiction Market
Mar 18 / GuruFocus News - Paid Partner Content
Is Pfizer (PFE) a Great Stock for Value Investors?
Mar 21 / Zacks.com - Paid Partner Content
Dow 30 Stock Roundup: Boeing Inks $3.3B U.S. Army Deal, Intel Buys Mobileye
Mar 17 / Zacks.com - Paid Partner Content
Lilly's Breast Cancer Combo Drug Phase III Results Positive
Mar 21 / Zacks.com - Paid Partner Content
Fired U.S. Attorney Preet Bharara Was Investigating HHS Chief Tom Price - Report
Mar 17 / TheStreet.com - Paid Partner Content
Trump, Biogen and Amgen Hammer Healthcare ETFs
Mar 20 / Zacks.com - Paid Partner Content
Britain's national champions can thrive without protection
Mar 17 / FT.com - Paid Partner Content

Today’s Trading

Previous close34.25
Today’s open34.30
Day’s range33.99 - 34.54
Volume26,117,870
Average volume (3 months)26,886,168
Market cap$204.0B
Dividend yield3.71%
Data as of 03/22/2017

Growth & Valuation

Earnings growth (last year)+5.09%
Earnings growth (this year)+6.53%
Earnings growth (next 5 years)+5.90%
Revenue growth (last year)+8.13%
P/E ratio29.5
Price/Sales3.79
Price/Book3.49

Competitors

 Today’s
change
Today’s
% change
MRKMerck-0.41-0.64%
NVSNovartis-0.20-0.27%
SNYSanofi+0.31+0.70%
ABBVAbbVie+0.17+0.26%
Data as of 03/22/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$0.67
Annual revenue (last year)$52.8B
Annual profit (last year)$7.2B
Net profit margin13.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts


Search for Jobs